Pharmaceuticals, Biotechnology and Life Sciences
Instem’s Acquisition of Leadscope, Inc. is Another Step in its Mission to Help Clients Bring Life Enhancing Products to Market…
PRINCETON, N.J. & NEW YORK–(BUSINESS WIRE)–The Bristol-Myers Squibb-Pfizer Alliance today announced the initiation of a new randomized, controlled study, GUARD-AF…
Lawsuits Against OncoSec Proceeding in Nevada District Court Remains Opposed to China Grand Transaction and Intends to Solicit Proxies from…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the…
HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) announced today that it has commenced a modified…
OPC1 Overall Safety Profile Excellent with Motor Recovery Gains in Upper Extremities Maintained Through Year 2 Follow-Ups Available to Date…
HONG KONG–(BUSINESS WIRE)–Aptorum Group Limited (Nasdaq: APM) (“the Company”) a biopharmaceutical company focused on the development of novel therapeutics to…
LEXINGTON, Mass.–(BUSINESS WIRE)–#RevitaDMR–Fractyl Laboratories Inc. (Fractyl) today announced that the company will present positive results from the long-term follow-up from…
Magazine honors the best employers in Massachusetts CAMBRIDGE, Mass.–(BUSINESS WIRE)–Beam Therapeutics, a biotechnology company developing precision genetic medicines through base…
REVLIMID® and rituximab (R2) has the potential to become a chemotherapy-free combination treatment option for patients with follicular lymphoma who…